ALX Oncology Holdings Inc. will participate in the Wells Fargo Executive Biotech Summit (one-on-one meetings) on Feb. 24–25, 2026 in Lake Tahoe, California; present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 9:10 a.m. EST in Boston, Massachusetts; and join the UBS Biotech Summit (one-on-one meetings) on March 10, 2026 in Miami, Florida. Event materials include the TD Cowen webcast link: https://www.globenewswire.com/Tracker?data=_1T28wdXVcSJnd_Cs3y9DItfvK7w5ayR0aotLNtdDj4H-x0ZUN1Njz3zwmVw0gioUazEgam8SxRDRm0bxWbQXVEbl19gVd7P_cXSfBanH-O7DXu5vpnK4uWr0qIZAfUk2UtAQzjuvId0OciITCGxcQ== and access via ALX Oncology’s Investors Events section: https://www.alxoncology.com.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602190833PRIMZONEFULLFEED9657379) on February 19, 2026, and is solely responsible for the information contained therein.